RCT in 482 infants born at 22-28 weeks with PDA, stopped after a 50% interim analysis: death or BPD was 80.9% with expectant management vs 79.6% with active treatment (not significant); death before 36 weeks was 4.1% vs 9.6%.
RCTn = 482
Laughon et al. Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial